pharma
Seqirus announces £40m UK fill-and-finish flu vaccine facility
November 9, 2017Manufacturing and Production Liverppol, Novartis, UK, Vaccine, flu, influenza, pharma, seqirus
Seqirus, an influenza vaccine specialist subsidiary of global biotech firm CSL, has announced a £40 million investment into a new …
NHS Chief in high-stakes gambit to boost funding in autumn budget
November 9, 2017Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
It speaks to the desperation of the funding crisis for the NHS that Chief Executive of the NHS, Simon Stevens, …
GSK indicates a return to oncology by appointing Roche veteran
November 9, 2017Medical Communications GSK, Hal Barron, biotech, drugs, pharma, pharmaceutical
GSK, under its new CEO, has made most of its waves recently not with approvals but with high-profile appointments, and …
17,000 English patients are surviving Stage 4 cancer for two years or more, new data shows
November 8, 2017Research and Development Cancer, bladder cancer, breast cancer, colon cancer, lung cancer, pharma, prostate cancer
At least 17,000 people in the UK are living with Stage 4 cancer and have survived for two years or …
The End Game: Payer Engagement Webinar
November 8, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, pharma, pharmaceutical
In our latest free to attend webinar, we have joined up with NDA to bring you the latest market access …
Cellectis given another shot at off-the-shelf CAR-T
November 8, 2017Medical Communications, Research and Development CAR-T, biotech, cellectis, drugs, pharma, pharmaceutical
It is easy to forget the very real dangers that CAR-T treatment present to patients after Novartis and Gilead both …
Clinical trials still have a problem with ethnic minorities
November 8, 2017Medical Communications, Research and Development biotech, clinical trials, drugs, ethnic minorities, pharma, pharmaceutical
Research, published in the Journal of Women’s Health, that aimed to determine the effects of the FDA’s guidance on the …
Novartis’ Kisqali smashes Phase 3 primary endpoint in breast cancer for second time
November 8, 2017Research and Development Cancer, Kisqali, Novartis, breast cancer, pharma
Novartis has revealed that its immunotherapy drug Kisqali (ribociclib) met its primary endpoint of progression-free survival in its second Phase …
Collaboration in Biopharma
November 7, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Dear Colleague,
Breathalyser for malaria shows promise in trials
November 7, 2017Manufacturing and Production, Research and Development biotech, drugs, malaria, pharma, pharmaceutical
Access to sophisticated rapid blood tests for malaria has improved dramatically in recent years but there are still issues in …
FDA expands Roche drug indication to approve first-ever treatment for rare blood cancer
November 7, 2017Manufacturing and Production, Sales and Marketing Cancer, Erdheim-Chester Disease, FDA, Roche, blood cancer, pharma
The FDA has announced the approval of Roche’s Zelboraf (vemurafenib) in the treatment of Erdheim-Chester Disease (ECD), expanding its already …
Takeda’s dengue vaccine surpasses Sanofi’s in P2 trial
November 7, 2017Manufacturing and Production, Sales and Marketing Sanofi, Takeda, biotech, drugs, pharma, pharmaceutical
Sanofi spent more than $1.5 billion and two decades to develop the first ever vaccine for dengue fever, only a …
Valeant backs away from female libido pill
November 7, 2017Manufacturing and Production, Sales and Marketing Addyi, Valeant, biotech, drugs, pharma, pharmaceutical
Only two years ago, Valeant was so keen to get involved with a pill reported to increase the female libido …
Clinical trial transparency: Letting the light in
November 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, clinical trial transparency, clinical trials, drugs, pharma, pharmaceutical
Transparency is one of those words for which the exact meaning has become clouded by murkier connotations. The chances are …
Merck KGaA posts promising osteoarthritis data
November 6, 2017Research and Development, Sales and Marketing Merck KGaA, biotech, drugs, pharma, pharmaceutical
Merck KGaA’s share price is 7% down over the course of the year – a year that, on the pharmaceutical …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
